These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20003252)

  • 21. A 22-year Northern Irish experience of carotid body tumours.
    O'Neill S; O'Donnell M; Harkin D; Loughrey M; Lee B; Blair P
    Ulster Med J; 2011 Sep; 80(3):133-40. PubMed ID: 23526121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative Imaging Features are Associated with Surgical Complications Following Carotid Body Tumor Resection.
    Straughan DM; Neychev VK; Sadowski SM; Ellis RJ; Thomas F; Patronas NJ; Pacak K; Kebebew E; Nilubol N
    World J Surg; 2015 Aug; 39(8):2084-9. PubMed ID: 25840820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant carotid body tumor: a case report.
    Dias Da Silva A; O'Donnell S; Gillespie D; Goff J; Shriver C; Rich N
    J Vasc Surg; 2000 Oct; 32(4):821-3. PubMed ID: 11013048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of carotid body tumor - Is Shamblin classification sufficient to predict surgical outcome?
    Law Y; Chan YC; Cheng SW
    Vascular; 2017 Apr; 25(2):184-189. PubMed ID: 27357283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of color doppler ultrasonography combined with computed tomography angiography and magnetic resonance angiography in the preoperative quantification and classification of carotid body tumors: a retrospective analysis.
    Zhiqiang L; Yihua W; Ying F; Shiwei Z; Xiangzhu Z; Ligang C
    BMC Med Imaging; 2024 Jan; 24(1):10. PubMed ID: 38172706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer.
    Skånberg J; Ahlman H; Benjegård SA; Fjälling M; Forssell-Aronsson EB; Hashemi SH; Nilsson O; Suurkula M; Jansson S
    Breast Cancer Res Treat; 2002 Jul; 74(2):101-11. PubMed ID: 12186370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A family exhibiting carotid body tumours.
    Borowy ZJ; Probst L; Deitel M; Shankar L
    Can J Surg; 1992 Oct; 35(5):546-51. PubMed ID: 1393873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct features of malignant carotid body tumors and surgical techniques for challengeable lesions: a case series of 11 patients.
    Gu G; Wang Y; Liu B; Chen Y; Shao J; Li F; Wu X; Cui L; Lu X; Liu C; Guan H; Gao Z; Feng G; Zheng Y
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):853-861. PubMed ID: 31807890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours.
    Castaldi P; Rufini V; Treglia G; Bruno I; Perotti G; Stifano G; Barbaro B; Giordano A
    Radiol Med; 2008 Oct; 113(7):1056-67. PubMed ID: 18797822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
    Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
    Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of malignancy and preoperative embolization in the management of carotid body tumors.
    Liapis CD; Evangelidakis EL; Papavassiliou VG; Kakisis JD; Gougoulakis AG; Polyzos AK; Sechas MN; Gogas JG
    World J Surg; 2000 Dec; 24(12):1526-30. PubMed ID: 11193718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical outcomes and factors associated with malignancy in carotid body tumors.
    Zhang W; Liu F; Hou K; Shu X; Chen B; Wang L; Guo D; Fu W
    J Vasc Surg; 2021 Aug; 74(2):586-591. PubMed ID: 33548423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, characteristics, evaluation, and management of carotid body tumors: Systematic analysis based on available evidence.
    Wang YH; Yang J; Zhong H; Wu JJ; Wu K; Hu A; Wu JY; Zhu JH
    J Vasc Surg; 2024 Aug; 80(2):574-585.e4. PubMed ID: 38580159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
    De Jong M; Valkema R; Jamar F; Kvols LK; Kwekkeboom DJ; Breeman WA; Bakker WH; Smith C; Pauwels S; Krenning EP
    Semin Nucl Med; 2002 Apr; 32(2):133-40. PubMed ID: 11965608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.
    Otte A; Jermann E; Behe M; Goetze M; Bucher HC; Roser HW; Heppeler A; Mueller-Brand J; Maecke HR
    Eur J Nucl Med; 1997 Jul; 24(7):792-5. PubMed ID: 9211767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in assessment and management of carotid body tumors.
    Avgerinos ED; Moulakakis K; Brountzos E; Giannakopoulos TG; Lazaris AM; Koumarianou A; Geronikola-Trapali X; Ptohis N; Papapetrou A; Liapis CD
    Vascular; 2011 Oct; 19(5):250-6. PubMed ID: 21844248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative angiography and transarterial embolization in the management of carotid body tumor: a single-center, 10-year experience.
    Li J; Wang S; Zee C; Yang J; Chen W; Zhuang W; Li X; Lv W; Huang Y; Li S
    Neurosurgery; 2010 Oct; 67(4):941-8; discussion 948. PubMed ID: 20881559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New predictors of complications in carotid body tumor resection.
    Kim GY; Lawrence PF; Moridzadeh RS; Zimmerman K; Munoz A; Luna-Ortiz K; Oderich GS; de Francisco J; Ospina J; Huertas S; de Souza LR; Bower TC; Farley S; Gelabert HA; Kret MR; Harris EJ; De Caridi G; Spinelli F; Smeds MR; Liapis CD; Kakisis J; Papapetrou AP; Debus ES; Behrendt CA; Kleinspehn E; Horton JD; Mussa FF; Cheng SWK; Morasch MD; Rasheed K; Bennett ME; Bismuth J; Lumsden AB; Abularrage CJ; Farber A
    J Vasc Surg; 2017 Jun; 65(6):1673-1679. PubMed ID: 28527929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.
    Dimitroulopoulos D; Xynopoulos D; Tsamakidis K; Paraskevas E; Zisimopoulos A; Andriotis E; Fotopoulou E; Kontis M; Paraskevas I
    World J Gastroenterol; 2004 Dec; 10(24):3628-33. PubMed ID: 15534919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].
    Banzo J; Abós MD; Prats E; García F; Freile E; Razola P; Escalera T
    Rev Esp Med Nucl; 2001 Oct; 20(6):431-8. PubMed ID: 11578577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.